Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
| Id | http://purl.bioontology.org/ontology/NDFRT/N0000003216
http://purl.bioontology.org/ontology/NDFRT/N0000003216
|
|---|---|
| Preferred Name | Tumor Lysis Syndrome [Disease/Finding] |
| Synonyms |
Tumor Lysis Syndrome
Tumour Lysis Syndrome
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
Tumor Lysis Syndrome
Tumour Lysis Syndrome
|
|---|---|
| prefLabel | Tumor Lysis Syndrome [Disease/Finding]
|
| notation | N0000003216
|
| May be treated by | |
| MESH DEFINITION | A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
|
| MESH UI | M0023515
|
| subClassOf | |
| Semantic type UMLS property | |
| MeSH name | Tumor Lysis Syndrome
|
| NDFRT kind | DISEASE_KIND
|
| type | |
| SNOMED CID | 277605001
|
| tui | T047
|
| NUI | N0000003216
|
| cui | C0041364
|
| MESH DUI | D015275
|
| May be prevented by |
See more
See less
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |